Bayesian Capital Management’s CME Group CME Stock Holding History

Bayesian Capital Management’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,800	Closed	-$418K	–	660
2024 Q4	$418K	Buy	+1,800	New	+$414K	0.05%	408
2024 Q1	–	Sell	-7,218	Closed	-$1.52M	–	819
2023 Q4	$1.52M	Buy	+7,218	New	+$1.54M	0.16%	162
2023 Q1	–	Sell	-18,520	Closed	-$3.11M	–	829
2022 Q4	$3.11M	Buy	18,520 +13,000	+236%	+$2.26M	0.46%	24
2022 Q3	$978K	Buy	+5,520	New	+$1.09M	0.2%	137
2021 Q3	–	Sell	-2,169	Closed	-$461K	–	405
2021 Q2	$461K	Buy	+2,169	New	+$458K	0.12%	203
2020 Q1	–	Sell	-1,300	Closed	-$261K	–	797
2019 Q4	$261K	Buy	+1,300	New	+$267K	0.04%	464
2019 Q1	–	Sell	-1,558	Closed	-$293K	–	579
2018 Q4	$293K	Buy	+1,558	New	+$288K	0.06%	418
2018 Q3	–	Sell	-1,625	Closed	-$266K	–	644
2018 Q2	$266K	Buy	1,625 +303	+23%	+$49.5K	0.06%	441
2018 Q1	$214K	Buy	+1,322	New	+$210K	0.05%	485

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TIM

Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bayesian Capital Management's CME Position: Q1 2025 in Review

Bayesian Capital Management sold out of CME Group (CME) in Q1 2025, closing a stake of 1,800 shares — an estimated $418K sold.

Bayesian Capital Management first reported a position in CME in Q1 2018 and held it in 9 quarters. The position peaked at $3.11M in Q4 2022. 1,596 funds tracked by Wall St. Rank hold CME as of Q1 2025.

Bayesian Capital Management reported no remaining CME Group position as of Q1 2025 after selling out during the quarter.
Bayesian Capital Management sold 1,800 CME Group shares in Q1 2025, an estimated $418K.
Bayesian Capital Management first reported a position in CME Group in Q1 2018 and held it in 9 quarters.
Bayesian Capital Management's CME Group position peaked at $3.11M in Q4 2022.
1,596 funds tracked by Wall St. Rank held CME Group as of Q1 2025.

Based on Bayesian Capital Management's 13F filing for Q1 2025, filed 15 May 2025.